I've had stage IV low-grade serous ovarian cancer for 34 years now. Yes, 34. I've had at least 10 surgeries, done...

Ovarian CancerNovember 1, 2026Written by Navis AI

The "Seeding" Concern - What Evidence Shows

Your worry about biopsy spreading cancer cells (called "tumor seeding") is understandable, but the actual risk is quite low:

  • Needle biopsy seeding occurs in approximately 0.003-0.009% of cases across cancer types
  • For ovarian cancer specifically, modern core needle biopsies have minimal documented seeding risk
  • The "pollen" analogy isn't quite accurate - cancer cells need very specific conditions to implant and grow, not just exposure to tissue

However, your concern isn't unfounded - it's just that the risk is extremely small compared to potential benefits.

Tell us what’s going on with ovarian cancer. 2 free answers, then a free account.

Why Your Doctors Want This Biopsy Now

After 34 years and multiple treatments, your tumor biology may have changed. Here's what they're likely looking for:

Molecular/Genetic Evolution:

  • Low-grade serous cancers can acquire new mutations over time
  • BRAF, KRAS, NRAS, MEK pathway alterations - these matter because targeted therapies exist (trametinib, binimetinib, dabrafenib combinations)
  • HER2 status - can change and opens treatment options
  • Homologous recombination deficiency (HRD) - affects PARP inhibitor eligibility
  • Microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR) - qualifies for immunotherapy

Treatment Resistance Patterns: According to NCCN Guidelines, low-grade serous ovarian cancer is relatively chemoresistant, but newer targeted therapies show promise when specific biomarkers are present.

Critical Questions to Ask Your Oncologist

Before deciding, ask them:

  1. "What specific biomarkers are you testing for, and what treatment options would each result open up?" (Make them be specific - not just "to see what's there")

  2. "Given my aortic involvement in 4 locations, what's the technical risk of THIS specific biopsy?" (Location matters - aortic biopsies carry different risks than peripheral tumors)

  3. "If the biopsy shows actionable targets, am I healthy enough for those treatments?" (After 10 surgeries and multiple therapies, your functional status matters)

  4. "What happens if I decline the biopsy - what's the default treatment plan?" (Understanding your alternatives is crucial)

  5. "Has my tumor shown any growth or change recently that prompted this recommendation NOW?" (Stable disease for years vs. recent changes affects the decision)

  6. "Can you do liquid biopsy (ctDNA) first to see if we can get this information from blood?" (Less invasive option, though not always as comprehensive)

The Real Decision Framework

Consider biopsy IF:

  • There are specific targeted therapies you haven't tried that require biomarker confirmation
  • Your disease has recently progressed or changed behavior
  • You're willing and able to undergo new treatment if actionable findings emerge
  • The biopsy location is technically feasible with acceptable risk

Consider declining IF:

  • You're not interested in further systemic therapy regardless of results
  • The biopsy location poses significant technical risk (aortic involvement is concerning)
  • You've already had comprehensive molecular testing on recent tissue
  • Your disease has been stable and you're managing well with current approach

Your Unique Situation

34 years with low-grade serous is remarkable - you're clearly doing something right in managing this disease. The fact that you've survived this long suggests:

  • Your tumor biology may be more indolent than typical
  • Your body has found some equilibrium with the disease
  • Quality of life considerations become increasingly important

The aortic involvement in 4 locations is significant - this affects both biopsy risk and future treatment options. Make sure your team includes interventional radiology input on the technical safety of accessing these sites.

Bottom Line

This isn't a simple yes/no decision. The value of the biopsy depends entirely on:

  1. Whether it will reveal actionable information you don't already have
  2. Whether you'd pursue treatment based on those findings
  3. Whether the technical risk is acceptable given the location

You have every right to ask for a detailed explanation of what they hope to learn and how it would change your management. After 34 years and 10 surgeries, you've earned the right to make an informed decision that aligns with YOUR goals - whether that's pursuing every possible treatment option or prioritizing quality of life.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Would you like help formulating specific questions for your oncology team, or would you like to discuss what "actionable" findings might mean for low-grade serous ovarian cancer specifically?

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Question asked:

I've had stage IV low-grade serous ovarian cancer for 34 years now. Yes, 34. I've had at least 10 surgeries, done traditional chemo, hot chemo washes (hi-tech & low-tech), lupron and other injections, multiple immunotherapies... Anyhow, drs want to do a new biopsy on one of the areas where I have cancer. Its attached itself along my aorta in 4 different places: heart, liver, kidneys and small intestines. I think when you do a biopsy, it opens up the tumor. Acts like pollen. I can't decide if it's even worth doing. Opinions?

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about Ovarian Cancer